ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/07/09 | 2,271 | 2,323 | 2,216 | 2,242 | -14 | -0.6% | 2,245,400 |
2019/07/08 | 2,313 | 2,327 | 2,237 | 2,256 | -82 | -3.5% | 2,225,300 |
2019/07/05 | 2,304 | 2,344 | 2,237 | 2,338 | +40 | +1.7% | 2,294,000 |
2019/07/04 | 2,397 | 2,407 | 2,286 | 2,298 | -77 | -3.2% | 3,393,300 |
2019/07/03 | 2,470 | 2,475 | 2,355 | 2,375 | -65 | -2.7% | 3,687,800 |
2019/07/02 | 2,380 | 2,482 | 2,377 | 2,440 | +75 | +3.2% | 4,921,300 |
2019/07/01 | 2,399 | 2,429 | 2,340 | 2,365 | -4 | -0.2% | 3,499,700 |
2019/06/28 | 2,270 | 2,394 | 2,253 | 2,369 | +84 | +3.7% | 3,987,000 |
2019/06/27 | 2,339 | 2,364 | 2,217 | 2,285 | -52 | -2.2% | 3,736,600 |
2019/06/26 | 2,389 | 2,420 | 2,304 | 2,337 | +16 | +0.7% | 4,450,100 |
2019/06/25 | 2,300 | 2,360 | 2,258 | 2,321 | +6 | +0.3% | 4,617,500 |
2019/06/24 | 2,185 | 2,377 | 2,184 | 2,315 | +140 | +6.4% | 8,457,900 |
2019/06/21 | 2,139 | 2,238 | 2,121 | 2,175 | -1 | ±0% | 3,861,100 |
2019/06/20 | 2,079 | 2,184 | 2,030 | 2,176 | +106 | +5.1% | 3,750,800 |
2019/06/19 | 2,145 | 2,147 | 2,051 | 2,070 | -58 | -2.7% | 2,904,700 |
2019/06/18 | 2,086 | 2,133 | 2,063 | 2,128 | +49 | +2.4% | 2,738,900 |
2019/06/17 | 2,139 | 2,148 | 2,058 | 2,079 | -23 | -1.1% | 2,297,000 |
2019/06/14 | 2,030 | 2,123 | 2,023 | 2,102 | +82 | +4.1% | 2,991,400 |
2019/06/13 | 2,000 | 2,034 | 1,992 | 2,020 | +24 | +1.2% | 1,672,000 |
2019/06/12 | 1,988 | 2,043 | 1,969 | 1,996 | +18 | +0.9% | 2,761,700 |
2019/06/11 | 2,063 | 2,078 | 1,975 | 1,978 | -108 | -5.2% | 5,028,500 |
2019/06/10 | 2,047 | 2,239 | 2,024 | 2,086 | +72 | +3.6% | 10,143,100 |
2019/06/07 | 1,979 | 2,015 | 1,936 | 2,014 | +40 | +2% | 2,630,300 |
2019/06/06 | 2,054 | 2,070 | 1,909 | 1,974 | -69 | -3.4% | 4,863,300 |
2019/06/05 | 2,095 | 2,134 | 2,015 | 2,043 | +22 | +1.1% | 4,941,100 |
2019/06/04 | 2,028 | 2,083 | 2,009 | 2,021 | +13 | +0.6% | 3,371,200 |
2019/06/03 | 1,962 | 2,054 | 1,960 | 2,008 | -4 | -0.2% | 4,257,300 |
2019/05/31 | 2,015 | 2,114 | 1,984 | 2,012 | -71 | -3.4% | 8,224,500 |
2019/05/30 | 2,210 | 2,238 | 2,041 | 2,083 | -151 | -6.8% | 7,607,500 |
2019/05/29 | 2,245 | 2,264 | 2,165 | 2,234 | -61 | -2.7% | 6,814,900 |
2019/05/28 | 2,047 | 2,296 | 2,035 | 2,295 | +278 | +13.8% | 14,092,100 |
2019/05/27 | 2,030 | 2,058 | 1,977 | 2,017 | ±0 | ±0% | 4,234,000 |
2019/05/24 | 2,055 | 2,070 | 1,920 | 2,017 | +12 | +0.6% | 11,276,800 |
2019/05/23 | 1,850 | 2,149 | 1,845 | 2,005 | +218 | +12.2% | 20,540,400 |
2019/05/22 | 1,700 | 1,834 | 1,668 | 1,787 | +130 | +7.8% | 7,808,500 |
2019/05/21 | 1,661 | 1,687 | 1,591 | 1,657 | -5 | -0.3% | 2,921,700 |
2019/05/20 | 1,675 | 1,724 | 1,632 | 1,662 | +2 | +0.1% | 3,433,300 |
2019/05/17 | 1,594 | 1,680 | 1,587 | 1,660 | +100 | +6.4% | 4,654,000 |
2019/05/16 | 1,505 | 1,624 | 1,488 | 1,560 | +58 | +3.9% | 5,431,500 |
2019/05/15 | 1,643 | 1,743 | 1,491 | 1,502 | +8 | +0.5% | 10,756,700 |
2019/05/14 | 1,403 | 1,497 | 1,401 | 1,494 | +29 | +2% | 1,406,700 |
2019/05/13 | 1,486 | 1,511 | 1,429 | 1,465 | -21 | -1.4% | 1,363,600 |
2019/05/10 | 1,465 | 1,513 | 1,463 | 1,486 | +21 | +1.4% | 1,255,500 |
2019/05/09 | 1,558 | 1,561 | 1,447 | 1,465 | -66 | -4.3% | 1,448,000 |
2019/05/08 | 1,530 | 1,560 | 1,502 | 1,531 | -26 | -1.7% | 1,262,900 |
2019/05/07 | 1,456 | 1,567 | 1,445 | 1,557 | +99 | +6.8% | 1,863,200 |
2019/04/26 | 1,457 | 1,489 | 1,427 | 1,458 | -10 | -0.7% | 1,271,800 |
2019/04/25 | 1,422 | 1,476 | 1,421 | 1,468 | +31 | +2.2% | 1,235,200 |
2019/04/24 | 1,417 | 1,455 | 1,412 | 1,437 | +20 | +1.4% | 1,094,500 |
2019/04/23 | 1,380 | 1,427 | 1,373 | 1,417 | +28 | +2% | 1,243,200 |
1451~
1500
件表示中 / 5113件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 89,500円 | +20.3% | - | 0.00% | 158.69倍 | 1.18倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 148,200円 | -2.4% | -52.3% | 3.85% | 17.74倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 211,000円 | +4.1% | -3.1% | 2.75% | 18.38倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ハートシード | 346,000円 | +174.2% | - | 0.00% | - | 10.38倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
JCRファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム